Genome surgery using Cas9 ribonucleoproteins for the treatment of age-related macular degeneration.
about
CRISPR-Cas Genome Surgery in Ophthalmology.CRISPR/Cas9 system: a powerful technology for in vivo and ex vivo gene therapy.Progress and Prospects of CRISPR/Cas Systems in Insects and Other Arthropods.The Promise and Challenge of In Vivo Delivery for Genome Therapeutics.Salvianolic Acid A Inhibits OX-LDL Effects on Exacerbating Choroidal Neovascularization via Downregulating CYLD.The Conspicuity of CRISPR-Cpf1 System as a Significant Breakthrough in Genome Editing.Modern Therapeutic Approaches for Noninfectious Ocular Diseases Involving Inflammation.In vivo genome editing in animals using AAV-CRISPR system: applications to translational research of human disease.CRISPR-mediated Ophthalmic Genome Surgery.In vivo genome editing thrives with diversified CRISPR technologies.CRISPR RNAs trigger innate immune responses in human cells.Guiding Lights in Genome Editing for Inherited Retinal Disorders: Implications for Gene and Cell Therapy.Translation of CRISPR Genome Surgery to the Bedside for Retinal Diseases.CRISPR/Cas9 mediated high efficiency knockout of the eye color gene Vermillion in Helicoverpa zea (Boddie).In Vivo Applications of CRISPR-Based Genome Editing in the Retina.CRISPR/Cas9-Mediated Treatment Ameliorates the Phenotype of the Epidermolytic Palmoplantar Keratoderma-like Mouse.VSV-G-Enveloped Vesicles for Traceless Delivery of CRISPR-Cas9.CRISPR/Cas9 genome surgery for retinal diseasesIn Vivo Genome Editing as a Therapeutic Approach
P2860
Q33745403-603C3BA3-0D78-410E-86E3-4A444846AD34Q38680345-7C26148D-3900-4614-BD58-E690B09A42A9Q41430829-71C5E5F3-95A8-45B0-84D6-9DB6C4C27016Q41919375-D8398CC7-EFEF-4A56-A0AB-EABDCCF00B6FQ42730614-6231682F-B5A4-4EC7-80E0-B7A9E5FB589EQ47299533-E4AABB1D-CEE4-4AFC-8E6C-1BA941707B33Q47442388-4CC7C8BB-E909-4925-94DF-B872E087C7EAQ47553772-4CCCC6C1-8D14-4DD1-8E6A-C353555C9624Q47612258-BBE1A319-C9C8-428F-9988-B6F401FE20F7Q52363995-76860E9C-CE09-4516-86F5-D0DD91633D8EQ52374559-189EBE48-7BD0-4165-A8F8-E4C939088FE9Q55000684-9432A996-E091-4C29-A2A1-FBB40B66C21CQ55180016-9ABFFBE2-07CC-4D6B-838A-E3A953501C4DQ55262296-BB1F52F3-5466-4DB4-A8E3-E299B6511CC0Q55262727-F94A7EBD-91E2-4B61-BF13-9F37C1E17CCCQ55364492-94A97D46-AA2A-4DCE-AA05-88847E83D895Q55546604-9B7B0D84-8B54-47F3-85CC-E836051128DBQ57171979-82E0A7F0-233D-4E04-AC4A-D5EAA7801903Q58745391-E6364EB2-C0D4-4700-88FC-6B96291D9B39
P2860
Genome surgery using Cas9 ribonucleoproteins for the treatment of age-related macular degeneration.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh
2017年學術文章
@zh-hant
name
Genome surgery using Cas9 ribo ...... -related macular degeneration.
@ast
Genome surgery using Cas9 ribo ...... -related macular degeneration.
@en
type
label
Genome surgery using Cas9 ribo ...... -related macular degeneration.
@ast
Genome surgery using Cas9 ribo ...... -related macular degeneration.
@en
prefLabel
Genome surgery using Cas9 ribo ...... -related macular degeneration.
@ast
Genome surgery using Cas9 ribo ...... -related macular degeneration.
@en
P2093
P2860
P356
P1433
P1476
Genome surgery using Cas9 ribo ...... -related macular degeneration.
@en
P2093
Daesik Kim
Jeong Hun Kim
Jin Hyoung Kim
Kwang-Eun Kim
Kyoungmi Kim
Seung Hwan Lee
Sung Wook Park
Taeyoung Koo
P2860
P304
P356
10.1101/GR.219089.116
P50
P577
2017-02-16T00:00:00Z